KRYS – Krystal Biotech, Inc.
Float Short %
10.73
Margin Of Safety %
-15
Put/Call OI Ratio
0.36
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
2.66
Price
262.11
Target Price
317.33
Analyst Recom
1
Performance Q
27.87
Upside
-8.6%
Beta
0.49
Ticker: KRYS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | KRYS | 281.62 | 0.39 | 3.75 | 5057 |
| 2026-01-26 | KRYS | 278.71 | 0.39 | 0.67 | 5065 |
| 2026-01-27 | KRYS | 277.51 | 0.39 | 0.50 | 5069 |
| 2026-01-28 | KRYS | 272.66 | 0.39 | 0.16 | 5075 |
| 2026-01-29 | KRYS | 279.42 | 0.39 | 1.00 | 5073 |
| 2026-01-30 | KRYS | 279.53 | 0.39 | 0.42 | 5073 |
| 2026-02-02 | KRYS | 282.29 | 0.39 | 0.02 | 5076 |
| 2026-02-03 | KRYS | 279.33 | 0.39 | 1.09 | 5110 |
| 2026-02-04 | KRYS | 268.86 | 0.40 | 0.19 | 5161 |
| 2026-02-05 | KRYS | 267.39 | 0.40 | 0.08 | 5203 |
| 2026-02-06 | KRYS | 272.3 | 0.40 | 0.08 | 5197 |
| 2026-02-09 | KRYS | 272.62 | 0.39 | 4.83 | 5217 |
| 2026-02-10 | KRYS | 270.14 | 0.45 | 0.40 | 5471 |
| 2026-02-11 | KRYS | 272.19 | 0.45 | 0.03 | 5505 |
| 2026-02-12 | KRYS | 270.99 | 0.40 | 8.83 | 6040 |
| 2026-02-13 | KRYS | 277.2 | 0.35 | 0.31 | 5858 |
| 2026-02-17 | KRYS | 287.35 | 0.35 | 0.38 | 6008 |
| 2026-02-18 | KRYS | 282.96 | 0.38 | 0.06 | 6504 |
| 2026-02-19 | KRYS | 262.98 | 0.38 | 0.21 | 6534 |
| 2026-02-20 | KRYS | 261.68 | 0.36 | 0.93 | 7391 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | KRYS | 281.55 | 5.0 | 199.3 | 6.54 |
| 2026-01-26 | KRYS | 278.76 | 5.0 | 206.5 | 6.54 |
| 2026-01-27 | KRYS | 277.64 | 5.0 | 208.9 | 6.54 |
| 2026-01-28 | KRYS | 272.83 | 5.0 | 203.8 | 6.54 |
| 2026-01-29 | KRYS | 279.34 | 5.0 | 220.4 | 6.54 |
| 2026-01-30 | KRYS | 279.43 | 5.0 | 209.8 | 6.54 |
| 2026-02-02 | KRYS | 282.55 | 5.0 | 215.1 | 6.54 |
| 2026-02-03 | KRYS | 279.42 | 5.0 | 206.4 | 6.54 |
| 2026-02-04 | KRYS | 268.92 | 5.0 | 195.1 | 6.54 |
| 2026-02-05 | KRYS | 267.57 | 5.0 | 208.0 | 6.54 |
| 2026-02-06 | KRYS | 272.48 | 5.0 | 218.0 | 6.54 |
| 2026-02-09 | KRYS | 272.41 | 5.0 | 210.6 | 6.54 |
| 2026-02-10 | KRYS | 270.20 | 5.0 | 206.9 | 6.54 |
| 2026-02-11 | KRYS | 272.55 | 5.0 | 213.6 | 6.54 |
| 2026-02-12 | KRYS | 270.26 | 5.0 | 207.4 | 6.54 |
| 2026-02-13 | KRYS | 277.14 | 5.0 | 220.9 | 6.54 |
| 2026-02-17 | KRYS | 287.89 | 5.0 | 226.9 | 6.54 |
| 2026-02-18 | KRYS | 282.96 | 5.0 | 204.3 | 6.54 |
| 2026-02-19 | KRYS | 262.54 | 5.0 | - | 6.54 |
| 2026-02-20 | KRYS | 262.11 | 15.1 | - | 7.75 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | KRYS | -2.40 | 2.81 | 10.75 |
| 2026-01-26 | KRYS | -2.40 | 2.94 | 10.75 |
| 2026-01-27 | KRYS | -2.40 | 2.94 | 10.75 |
| 2026-01-28 | KRYS | -2.40 | 2.94 | 10.66 |
| 2026-01-29 | KRYS | -2.40 | 2.94 | 10.66 |
| 2026-01-30 | KRYS | -2.40 | 2.94 | 10.66 |
| 2026-02-02 | KRYS | -2.40 | 2.87 | 10.66 |
| 2026-02-03 | KRYS | -2.40 | 2.87 | 10.66 |
| 2026-02-04 | KRYS | -2.40 | 2.87 | 10.66 |
| 2026-02-05 | KRYS | -2.40 | 2.87 | 10.66 |
| 2026-02-06 | KRYS | -2.40 | 2.87 | 10.66 |
| 2026-02-09 | KRYS | -2.40 | 2.73 | 10.66 |
| 2026-02-10 | KRYS | -2.40 | 2.73 | 10.66 |
| 2026-02-11 | KRYS | -2.40 | 2.73 | 10.89 |
| 2026-02-12 | KRYS | -2.69 | 2.73 | 10.89 |
| 2026-02-13 | KRYS | -2.69 | 2.73 | 10.89 |
| 2026-02-17 | KRYS | -2.69 | 4.80 | 10.88 |
| 2026-02-18 | KRYS | -2.70 | 4.80 | 10.88 |
| 2026-02-19 | KRYS | -2.70 | 4.80 | 10.88 |
| 2026-02-20 | KRYS | -2.68 | 4.80 | 10.73 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
1.38
Avg. EPS Est. Next Quarter
1.66
Insider Transactions
-2.68
Institutional Transactions
4.8
Beta
0.49
Average Sales Estimate Current Quarter
113
Average Sales Estimate Next Quarter
127
Fair Value
224.01
Quality Score
91
Growth Score
39
Sentiment Score
58
Actual DrawDown %
12.1
Max Drawdown 5-Year %
-53.4
Target Price
317.33
P/E
38.25
Forward P/E
25.97
PEG
1.04
P/S
19.67
P/B
6.27
P/Free Cash Flow
40.51
EPS
6.84
Average EPS Est. Cur. Y
7.75
EPS Next Y. (Est.)
10.42
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
52.64
Relative Volume
1.1
Return on Equity vs Sector %
-11.5
Return on Equity vs Industry %
5.9
EPS 1 7Days Diff
-0.6
EPS 1 30Days Diff
-0.69
EBIT Estimation
Krystal Biotech, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 295
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today
news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance
stock history KRYS – Krystal Biotech, Inc. invest stock market
stock prices KRYS premarket after hours
ticker KRYS fair value insiders trading